Should doctors prescribe Leqembi (lecanemab) to women with early Alzheimer ’s Disease? The evidence-based answer is probably No

Welcome to a new edition of SharpBrains e‑newsletter, featuring this time a range of interventions for brain/ cognitive/ mental health plus a few brain teasers to test our perception and cognitive skills. #1. Should doctors prescribe lecanemab (Leqembi) to women? The answer, given available evidence, is probably No Huge (and mostly overlooked) red flag regarding newly approved “anti-Alzheimer’s” drugs: “To put it bluntly, if lecanemab doesn’t work in women it would be unethical to supply it to women. Recall this costly immunotherapy comes with substantive risks, including high incidence of ARIA and even death.” #2. Growing controversy over role of FDA and Medicare in promoting anti-amyloid drugs given limited benefit, high cost, severe side-effects There’s even a petition circulating among scientists and doctors stating that “As the FDA prepares to determine if it will grant full approval for its widespread use, the available data suggests lecanemab is ineffective and may be harmful, making its use and cost unjustifiable.” #3. How the Arts transform our Brains, Bodies, and Minds “The arts can transform you like nothing else.” #4. Smartphone-based cognitive behavioral therapy found to significantly decrease insomnia, substantially outperforming sleep education Capabilities > Knowledge #5. Study shows the power of electroencephalography and machine learning to help predict response to psychotherapy (or lack thereof) in patients with PTSD “N...
Source: SharpBrains - Category: Neuroscience Authors: Tags: Brain/ Mental Health SharpBrains Monthly eNewsletter Technology & Innovation ADHD-symptoms Alzheimers-disease Anti-Alzheimer’s Drugs anti-amyloid drugs ARIA Brain Teasers brain teasers for adults cognitive-behavioral-therapy cognit Source Type: blogs